We hypothesize further that pretreatment with IFN-γ and a PD-1-blockading agent may play a crucial role in effective adoptive transfer treatments of pancreatic cancer, although this disease is characterized by its low immunogenicity. Here, PDCD1 is linked to familial pancreatic carcinoma.